289 related articles for article (PubMed ID: 26518014)
1. Central Anticholinergic Adverse Effects and Their Measurement.
Lampela P; Paajanen T; Hartikainen S; Huupponen R
Drugs Aging; 2015 Dec; 32(12):963-74. PubMed ID: 26518014
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
[TBL] [Abstract][Full Text] [Related]
3. Drugs with anticholinergic properties: a current perspective on use and safety.
Gerretsen P; Pollock BG
Expert Opin Drug Saf; 2011 Sep; 10(5):751-65. PubMed ID: 21635190
[TBL] [Abstract][Full Text] [Related]
4. [The adverse effects of anticholinergic drugs].
Iwaki H; Nomoto M
Brain Nerve; 2014 May; 66(5):551-60. PubMed ID: 24807371
[TBL] [Abstract][Full Text] [Related]
5. Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.
Ogino S; Miyamoto S; Miyake N; Yamaguchi N
Psychiatry Clin Neurosci; 2014 Jan; 68(1):37-49. PubMed ID: 24102938
[TBL] [Abstract][Full Text] [Related]
6. Association between anticholinergic burden and anticholinergic adverse outcomes in the elderly: Pharmacological basis of their predictive value for adverse outcomes.
Lavrador M; Castel-Branco MM; Cabral AC; Veríssimo MT; Figueiredo IV; Fernandez-Llimos F
Pharmacol Res; 2021 Jan; 163():105306. PubMed ID: 33248197
[TBL] [Abstract][Full Text] [Related]
7. The effects of anticholinergic drugs on attention span and short-term memory skills in children.
Giramonti KM; Kogan BA; Halpern LF
Neurourol Urodyn; 2008; 27(4):315-8. PubMed ID: 17828786
[TBL] [Abstract][Full Text] [Related]
8. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
9. Drugs with anticholinergic side-effects in primary care.
Yayla EM; Yavuz E; Bilge U; Keskin A; Binen E
Niger J Clin Pract; 2015; 18(1):18-21. PubMed ID: 25511338
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.
Lampela P; Lavikainen P; Garcia-Horsman JA; Bell JS; Huupponen R; Hartikainen S
Drugs Aging; 2013 May; 30(5):321-30. PubMed ID: 23475596
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review.
Salahudeen MS; Duffull SB; Nishtala PS
BMC Geriatr; 2015 Mar; 15():31. PubMed ID: 25879993
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate anticholinergic drugs prescriptions in older patients: analysing a hospital database.
Ferret L; Ficheur G; Delaviez E; Luyckx M; Quenton S; Beuscart R; Chazard E; Beuscart JB
Int J Clin Pharm; 2018 Feb; 40(1):94-100. PubMed ID: 29147963
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly.
Scheife R; Takeda M
Clin Ther; 2005 Feb; 27(2):144-53. PubMed ID: 15811477
[TBL] [Abstract][Full Text] [Related]
14. Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.
Attoh-Mensah E; Loggia G; Schumann-Bard P; Morello R; Descatoire P; Marcelli C; Chavoix C
Drugs Aging; 2020 Apr; 37(4):301-310. PubMed ID: 31930459
[TBL] [Abstract][Full Text] [Related]
15. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
[TBL] [Abstract][Full Text] [Related]
16. Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs.
Kersten H; Wyller TB; Molden E
Ther Drug Monit; 2014 Feb; 36(1):125-30. PubMed ID: 24089073
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effects of intrarectal administration of oxybutynin].
Radziszewski P; Borkowski A
Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
Konishi K; Hori K; Uchida H; Watanabe K; Tominaga I; Kimura M; Hosoyamada M; Shibasaki T; Kataoka A; Hachisu M
Psychogeriatrics; 2010 Mar; 10(1):34-8. PubMed ID: 20594285
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergics: theoretical and clinical overview.
Nishtala PS; Salahudeen MS; Hilmer SN
Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anticholinergic burden of medications in older adults.
West T; Pruchnicki MC; Porter K; Emptage R
J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
